Primary Job Title Chief Medical Officer Primary Organization Neuron23
Location San Francisco Bay Area, California, United States Regions West Coast, Western US Gender Male
LinkedIn View on LinkedIn
Sam Jackson currently works as Chief Medical Officer for Neuron23. Before joining Neuron23, Dr. Jackson served as senior vice president and CMO at Alector, where he oversaw the clinical teams developing the company's immuno-neurology therapies for Frontotemporal dementia, Alzheimer's disease, and other neurodegenerative conditions. He
also served as CMO of Alkahest, helping build the clinical organization and initiating four Phase 2 trials in neurological and ophthalmologic diseases. Earlier in his career, at Dynavax Technologies, Dr. Jackson ran the final pivotal Phase 3 trial that resulted in product approval for HEPLISAV-B™, and also held positions of increasing responsibility at Genentech, Inc., and Amgen.Dr. Jackson holds a joint M.D./MBA degree from the Perelman School of Medicine and The Wharton School of Business at the University of Pennsylvania and earned his undergraduate degree in English from Stanford University. He completed his residency in emergency medicine at the University of California Davis Medical Center in Sacramento, California, and his fellowship in medical toxicology at the Banner Good Samaritan Hospital in Phoenix, Arizona.
